Arthritis in Kawasaki disease after responding to intravenous immunoglobulin treatment.
Lee
Kyung-Yil
KY
Department of Paediatrics, The Catholic University of Korea, Daejeon St. Mary's Hospital, 520-2 Daeheung 2-dong, Jung-gu, 301-723 Daejeon, Republic of Korea. leekyungyil@catholic.ac.kr
Oh
Jin-Hee
JH
Han
Ji-Whan
JW
Lee
Joon-Sung
JS
Lee
Byung-Churl
BC
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D016918:Arthritis, Reactive / Q000209:etiology*; D001241:Aspirin / Q000008:administration & dosage; D002675:Child, Preschool; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications* / Q000188:drug therapy
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D001241:Aspirin